Evidence map›Paper›PMID 29963014›Full record

ArticleFrontiers in endocrinology2018

Alice B Nongonierma, Luca Dellafiora, Sara Paolella, Gianni Galaverna, Pietro Cozzini, Richard J FitzGerald

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Seaweed (Journal of agricultural and food chemistry · 2025
    Article
  5. Review
  6. Article
  7. Review
  8. In Silico Hydrolysis of Lupin (International journal of molecular sciences · 2024
    Article
  9. Precooked Jack Bean [Preventive nutrition and food science · 2024
    Article
  10. Article
  11. Encapsulation ofNanomaterials (Basel, Switzerland) · 2024
    Article
  12. Computational Modeling of the Interactions between DPP IV and Hemorphins.International journal of molecular sciences · 2024
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Alice B NongoniermaDepartment of Biological Sciences and Food for Health Ireland (FHI), University of Limerick, Limerick, Ireland.
Luca DellafioraFood and Drug Department, University of Parma, Parma, Italy.
Sara PaolellaDepartment of Biological Sciences and Food for Health Ireland (FHI), University of Limerick, Limerick, Ireland.
Gianni GalavernaFood and Drug Department, University of Parma, Parma, Italy.
Pietro CozziniFood and Drug Department, University of Parma, Parma, Italy.
Richard J FitzGeraldDepartment of Biological Sciences and Food for Health Ireland (FHI), University of Limerick, Limerick, Ireland.
University of Parma · ITFood for Health Ireland · IEUniversity of Limerick · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inhibition of dipeptidyl peptidase IV (DPP-IV) may be exploited to maintain the incretin effect during the postprandial phase. As a result, glycemic regulation and energy homeostasis may be improved. Food protein-derived peptides have been identified as natural agents capable of inhibiting DPP-IV. Ile-Pro-Ile is the most potent DPP-IV inhibitory peptide identified to date. A minimum analog peptide set approach was used to study peptide analogs of Ile-Pro-Ile. The DPP-IV half maximal inhibitory concentration (IC

Indexed as

bioactive peptidesdesign of experimentsdipeptidyl peptidase IV inhibitionIle-Pro-Ile (diprotin A)molecular dockingpeptide analogsquantitative structure activity relationship

Identifiers

PMID29963014
PMCPMC6010526
OpenAlexW2805280630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.